+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Veterinary Oncology Diagnostics Market Size, Share & Trends Analysis Report By Animal Type (Canine, Feline), By Test Type, By Cancer Type, By End-use, By Region, And Segment Forecasts, 2025 - 2030

  • PDF Icon

    Report

  • 150 Pages
  • January 2025
  • Region: Global
  • Grand View Research
  • ID: 6052277
The global veterinary oncology diagnostics market is expected to reach USD 3.45 billion by 2030, registering a CAGR of 8.4% from 2025 to 2030. The market is primarily driven by growing animal population and ownership rates, increased expenditure on animals, shifting focus on preventative animal healthcare, advances in veterinary cancer diagnostic testing, and rising R&D investment in animal health diagnostics to launch innovative products. For instance, in December 2024, Pet Preferred Diagnostics introduced a groundbreaking early cancer diagnostic test for dogs and cats that detects 11 specific onconeural antibodies linked to 21 types of tumors and 14 neurological diseases. This highly sensitive serological test can identify malignancy, often before clinical signs appear, enabling early treatment. It is the only test available in veterinary medicine that differentiates various tumors and neurological conditions, offering a non-invasive, affordable, and quick solution with a 24-hour turnaround.

Additionally, the development of advanced veterinary cancer diagnostic tests, such as the world's first and only at-home cancer screening test by Oncotect, is creating lucrative opportunities in the veterinary oncology diagnostics market. This innovative canine cancer screening test enables early detection, improving treatment outcomes and offering peace of mind to pet owners. Oncotect, which detects the four most prevalent types of canine cancer, can be used at home or in-clinic, making it user-friendly and accessible. The rise in at-home testing solutions, coupled with clinical data supporting its accuracy, is expanding the market for veterinary oncology diagnostics, particularly by increasing accessibility for pet parents.

Furthermore, the increasing prevalence of cancer in pets is significantly driving the growth of the veterinary oncology diagnostics market. As per The Veterinary Cancer Society, Cancer is the top reason of death in 47% of canines, particularly those over 10 years old, and in 32% of felines. Around 1 in 4 dogs will experience abnormal tissue growth, or neoplasia, during their lifetime. With nearly 100 types of cancer affecting pets, a diagnosis can be overwhelming, yet advances in veterinary care have improved treatment success rates for both dogs and cats. Similarly, cancer is the leading cause of death in cats and dogs, affecting one in four dogs and one in five cats in Australia, according to a May 2024 study by the Australian Research Data Commons (ARDC). In the U.S., about 6 million pet dogs are expected to be diagnosed with cancer in 2024, creating a unique opportunity to improve cancer diagnosis for both pets and humans, as reported by The Cancer Letter Inc. Additionally, the American Veterinary Association states that one in four dogs will develop neoplasia at some point, and about half of dogs over the age of 10 will develop cancer.

Veterinary Oncology Diagnostics Market Report Highlights

  • By test type, the biopsy segment dominated the market with a share of 32.08% in 2024. However, the genome testing segment is expected to grow at the fastest CAGR of 9.48% during the forecast period due to technological advancements in veterinary cancer diagnostic test kits.
  • In terms of animal type, the canine segment attributed to the largest market share in 2024 due to the increase in the dog cancer population and the availability of a huge number of products for canine cancer diagnosis. The feline segment is projected to grow at the fastest rate from 2025 to 2030, owing to the rising population of cats worldwide and the apparent rise in the number of associated diseases.
  • In terms of cancer type, the skin cancers segment accounted for the highest market share in 2024 and is expected to grow at the fastest CAGR of 8.56% owing to the rising prevalence of squamous cell carcinoma and skin tumors in cats and dogs.
  • By end use, the veterinary hospitals and clinics segment held the highest share of the market in 2024 owing to the increasing demand for diagnostics and readily accessible advanced veterinary cancer diagnostic technologies in hospitals. This segment is estimated to grow at the fastest CAGR in the coming years.
  • By region, North America had the largest share, 53.9%, of the market in 2024 and is anticipated to grow the fastest, at 8.6%, in the coming years.
  • Advances in innovative liquid biopsy and advanced multi-cancer diagnostic technology have led to the development of more accurate, user-friendly, and cost-effective veterinary oncology diagnostic test kits. Such advancements are expected to drive market growth.

This product will be delivered within 1-3 business days.

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased Database
1.3.2. Internal Database
1.3.3. Secondary Sources
1.3.4. Primary Research
1.4. Information/Data Analysis
1.5. Market Formulation & Visualization
1.6. Data Validation & Publishing
1.7. Model Details
1.7.1. Commodity flow analysis
1.7.2. Global Market: CAGR Calculation
1.8. List of Secondary Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights
Chapter 3. Veterinary Oncology Diagnostics Market Variable Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market
3.1.2. Ancillary Market
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Increasing prevalence of cancer in pets
3.2.1.2. Increasing R&D in veterinary oncolgy diagnostics
3.2.1.3. Growing focus on animal safety
3.2.1.4. Growing uptake of pet insurance
3.2.1.5. Technological advancements in early pet cancer diagnosis
3.2.1.6. Increase in pet population
3.2.2. Market Restraint Analysis
3.2.2.1. High cost of veterinary oncology diagnostics
3.2.2.2. Lack of awareness in developing countries
3.2.3. Market Opportunity Analysis
3.2.4. Market Challenge Analysis
3.3. Veterinary Oncology Diagnostics Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.1.1. Bargaining power of suppliers
3.3.1.2. Bargaining power of buyers
3.3.1.3. Threat of substitution
3.3.1.4. Threat of new entrants
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political & Legal Landscape
3.3.2.2. Economic and Social Landscape
3.3.2.3. Technological landscape
3.3.2.4. Environmental Landscape
3.3.3. Regulatory Framework
3.3.4. Estimated Animal Population, by Key Countries and Key Species, 2018-2024
3.3.5. COVID-19 Impact Analysis
Chapter 4. Veterinary Oncology Diagnostics Market: Animal Type Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Veterinary Oncology Diagnostics Market Animal Type Movement Analysis
4.3. Veterinary Oncology Diagnostics Market Size & Trend Analysis, By Animal Type, 2018 - 2030 (USD Million)
4.3.1. Canine
4.3.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.3.2. Feline
4.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
4.3.3. Others
4.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Veterinary Oncology Diagnostics Market: Test Type Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Veterinary Oncology Diagnostics Market Test Type Movement Analysis
5.3. Veterinary Oncology Diagnostics Market Size & Trend Analysis, By Test Type 2018 - 2030 (USD Million)
5.3.1. Blood Tests
5.3.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.3.2. Biopsy
5.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.3.3. Genome testing
5.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.3.4. Endoscopy
5.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.3.5. Urinalysis
5.3.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
5.3.6. Imaging
5.3.6.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Veterinary Oncology Diagnostics Market: Cancer Type Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Veterinary Oncology Diagnostics Market Cancer Type Movement Analysis
6.3. Veterinary Oncology Diagnostics Market Size & Trend Analysis, By Cancer Type, 2018 - 2030 (USD Million)
6.3.1. Lymphoma
6.3.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.3.2. Sarcomas
6.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.3.3. Mammary Gland Tumors
6.3.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.3.4. Skin Cancers
6.3.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
6.3.5. Others
6.3.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Veterinary Oncology Diagnostics Market: End Use Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Veterinary Oncology Diagnostics Market End-Use Movement Analysis
7.3. Veterinary Oncology Diagnostics Market Size & Trend Analysis, By End-Use 2018 - 2030 (USD Million)
7.3.1. Reference Laboratories
7.3.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
7.3.2. Veterinary hospitals and clinics
7.3.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 8. Veterinary Oncology Diagnostics Market: Country Estimates & Trend Analysis
8.1. Regional Dashboard
8.2. Veterinary Oncology Diagnostics Market Share, By Region, 2023 & 2030, USD Million
8.3. Regional Outlook
8.4. North America
8.4.1. North America Veterinary Oncology Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.4.2. U.S.
8.4.2.1. Key Country Dynamics
8.4.2.2. Competition Insights
8.4.2.3. U.S. Veterinary Oncology Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million) 8.4.3. Canada
8.4.3.1. Key Country Dynamics
8.4.3.2. Competition Insights
8.4.3.3. Canada Veterinary Oncology Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.4.4. Mexico
8.4.4.1. Key Country Dynamics
8.4.4.2. Competition Insights
8.4.4.3. Mexico Veterinary Oncology Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5. Europe
8.5.1. Europe Veterinary Oncology Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.2. UK
8.5.2.1. Key Country Dynamics
8.5.2.2. Competition Insights
8.5.2.3. UK Veterinary Oncology Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.3. Germany
8.5.3.1. Key Country Dynamics
8.5.3.2. Competition Insights
8.5.3.3. Germany Veterinary Oncology Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.4. France
8.5.4.1. Key Country Dynamics
8.5.4.2. Competition Insights
8.5.4.3. France Veterinary Oncology Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.5. Italy
8.5.5.1. Key Country Dynamics
8.5.5.2. Competition Insights
8.5.5.3. Italy Veterinary Oncology Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.6. Spain
8.5.6.1. Key Country Dynamics
8.5.6.2. Competition Insights
8.5.6.3. Spain Veterinary Oncology Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.7. Denmark
8.5.7.1. Key Country Dynamics
8.5.7.2. Competition Insights
8.5.7.3. Denmark Veterinary Oncology Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.8. Sweden
8.5.8.1. Key Country Dynamics
8.5.8.2. Competition Insights
8.5.8.3. Sweden Veterinary Oncology Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.5.9. Norway
8.5.9.1. Key Country Dynamics
8.5.9.2. Competition Insights
8.5.9.3. Norway Veterinary Oncology Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.6. Asia Pacific
8.6.1. Asia Pacific Veterinary Oncology Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.6.2. Japan
8.6.2.1. Key Country Dynamics
8.6.2.2. Competition Insights
8.6.2.3. Japan Veterinary Oncology Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.6.3. China
8.6.3.1. Key Country Dynamics
8.6.3.2. Competition Insights
8.6.3.3. China Veterinary Oncology Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.6.4. India
8.6.4.1. Key Country Dynamics
8.6.4.2. Competition Insights
8.6.4.3. India Veterinary Oncology Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.6.5. Australia
8.6.5.1. Key Country Dynamics
8.6.5.2. Competition Insights
8.6.5.3. Australia Veterinary Oncology Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.6.6. South Korea
8.6.6.1. Key Country Dynamics
8.6.6.2. Competition Insights
8.6.6.3. South Korea Veterinary Oncology Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.6.7. Thailand
8.6.7.1. Key Country Dynamics
8.6.7.2. Competition Insights
8.6.7.3. Thailand Veterinary Oncology Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.7. Latin America
8.7.1. Latin America Veterinary Oncology Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.7.2. Brazil
8.7.2.1. Key Country Dynamics
8.7.2.2. Competition Insights
8.7.2.3. Brazil Veterinary Oncology Diagnostics Market Estimates And Forecasts, 2018 - 2030
8.7.3. Argentina
8.7.3.1. Key Country Dynamics
8.7.3.2. Competition Insights
8.7.3.3. Argentina Veterinary Oncology Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.8. Middle East & Africa
8.8.1. Middle East & Africa Veterinary Oncology Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.8.2. South Africa
8.8.2.1. Key Country Dynamics
8.8.2.2. Competition Insights
8.8.2.3. South Africa Veterinary Oncology Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.8.3. Saudi Arabia
8.8.3.1. Key Country Dynamics
8.8.3.2. Competition Insights
8.8.3.3. Saudi Arabia Veterinary Oncology Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.8.4. UAE
8.8.4.1. Key Country Dynamics
8.8.4.2. Competition Insights
8.8.4.3. UAE Veterinary Oncology Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
8.8.5. Kuwait
8.8.5.1. Key Country Dynamics
8.8.5.2. Competition Insights
8.8.5.3. Kuwait Veterinary Oncology Diagnostics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
Chapter 9. Competitive Landscape
9.1. Market Participant Categorization
9.2. Participants Overview
9.3. Financial Performance
9.4. Product Benchmarking
9.5. Market Position Analysis, 2024 (Heat Map Analysis)
9.6. Strategy Mapping
9.6.1. MERGERS AND ACQUISITIONS
9.6.2. LAUNCH
9.6.3. PARTNERSHIPS & COLLABORATIONS
9.6.4. EXPANSION
9.6.5. OTHERS
9.7. Company Profiles
9.7.1. Zoetis
9.7.1.1. Participant’s overview
9.7.1.2. Financial performance
9.7.1.3. Product Benchmarking
9.7.1.4. Strategic initiatives
9.7.2. Antech Diagnostics, Inc. (Mars Inc.)
9.7.2.1. Participant’s overview
9.7.2.2. Financial performance
9.7.2.3. Product Benchmarking
9.7.2.4. Strategic initiatives
9.7.3. IDEXX Laboratories, Inc.
9.7.3.1. Participant’s overview
9.7.3.2. Financial performance
9.7.3.3. Product Benchmarking
9.7.3.4. Strategic initiatives
9.7.4. Neogen Corporation
9.7.4.1. Participant’s overview
9.7.4.2. Financial performance
9.7.4.3. Product Benchmarking
9.7.4.4. Strategic initiatives
9.7.5. Gold Standard Diagnostics (Eurofins Technologies)
9.7.5.1. Participant’s overview
9.7.5.2. Financial performance
9.7.5.3. Product Benchmarking
9.7.5.4. Strategic initiatives
9.7.6. Embark Veterinary, Inc.
9.7.6.1. Participant’s overview
9.7.6.2. Financial performance
9.7.6.3. Product Benchmarking
9.7.6.4. Strategic initiatives
9.7.7. VolitionRx Limited
9.7.7.1. Participant’s overview
9.7.7.2. Financial performance
9.7.7.3. Product Benchmarking
9.7.7.4. Strategic initiatives
9.7.8. CANCAN DIAGNOSTICS
9.7.8.1. Participant’s overview
9.7.8.2. Financial performance
9.7.8.3. Product Benchmarking
9.7.8.4. Strategic initiatives
9.7.9. Oncotect
9.7.9.1. Participant’s overview
9.7.9.2. Financial performance
9.7.9.3. Product Benchmarking
9.7.9.4. Strategic initiatives
9.7.10. PetDx
9.7.10.1. Participant’s overview
9.7.10.2. Financial performance
9.7.10.3. Product Benchmarking
9.7.10.4. Strategic initiatives
9.8. List of Other Market Players
Chapter 10. Key Takeaways
List of Tables
Tables 1 List of Secondary Sources
Tables 2 List of Abbreviations
Tables 3 Global Veterinary Oncology Diagnostics Market, by Animal, 2018 - 2030 (USD Million)
Tables 4 Global Veterinary Oncology Diagnostics Market, by Test Type, 2018 - 2030 (USD Million)
Tables 5 Global Veterinary Oncology Diagnostics Market, by Cancer Type, 2018 - 2030 (USD Million)
Tables 6 Global Veterinary Oncology Diagnostics Market, by End-Use, 2018 - 2030 (USD Million)
Tables 7 North America Veterinary Oncology Diagnostics Market, by country, 2018 - 2030 (USD
Tables 8 North America Veterinary Oncology Diagnostics Market, by Animal, 2018 - 2030 (USD Million)
Tables 9 North America Veterinary Oncology Diagnostics Market, by Test Type, 2018 - 2030 (USD Million)
Tables 10 North America Veterinary Oncology Diagnostics Market, by Cancer Type, 2018 - 2030 (USD Million)
Tables 11 North America Veterinary Oncology Diagnostics Market, by End-Use, 2018 - 2030 (USD Million)
Tables 12 U.S Veterinary Oncology Diagnostics Market, by Animal, 2018 - 2030 (USD Million)
Tables 13 U.S Veterinary Oncology Diagnostics Market, by Test Type, 2018 - 2030 (USD Million)
Tables 14 U.S Veterinary Oncology Diagnostics Market, by Cancer Type, 2018 - 2030 (USD Million)
Tables 15 U.S Veterinary Oncology Diagnostics Market, by End-Use, 2018 - 2030 (USD Million)
Tables 16 Canada Veterinary Oncology Diagnostics Market, by Animal, 2018 - 2030 (USD Million)
Tables 17 Canada Veterinary Oncology Diagnostics Market, by Test Type, 2018 - 2030 (USD Million)
Tables 18 Canada Veterinary Oncology Diagnostics Market, by Cancer Type, 2018 - 2030 (USD Million)
Tables 19 Canada Veterinary Oncology Diagnostics Market, by End-Use, 2018 - 2030 (USD Million)
Tables 20 Mexico Veterinary Oncology Diagnostics Market, by Animal, 2018 - 2030 (USD Million)
Tables 21 Mexico Veterinary Oncology Diagnostics Market, by Test Type, 2018 - 2030 (USD Million)
Tables 22 Mexico Veterinary Oncology Diagnostics Market, by Cancer Type, 2018 - 2030 (USD Million)
Tables 23 Mexico Veterinary Oncology Diagnostics Market, by End-Use, 2018 - 2030 (USD Million)
Tables 24 Europe Veterinary Oncology Diagnostics Market, by country, 2018 - 2030 (USD Million)
Tables 25 Europe Veterinary Oncology Diagnostics Market, by Test Type, 2018 - 2030 (USD Million)
Tables 26 Europe Veterinary Oncology Diagnostics Market, by animal type, 2018 - 2030 (USD Million)
Tables 27 Europe Veterinary Oncology Diagnostics Market, by cancer type, 2018 - 2030 (USD Million)
Tables 28 Europe Veterinary Oncology Diagnostics Market, by End-Use, 2018 - 2030 (USD Million)
Tables 29 Germany Veterinary Oncology Diagnostics Market, by Test Type, 2018 - 2030 (USD Million)
Tables 30 Germany Veterinary Oncology Diagnostics Market, by animal type, 2018 - 2030 (USD Million)
Tables 31 Germany Veterinary Oncology Diagnostics Market, by cancer type, 2018 - 2030 (USD Million)
Tables 32 Germany Veterinary Oncology Diagnostics Market, by End-Use, 2018 - 2030 (USD Million)
Tables 33 U.K Veterinary Oncology Diagnostics Market, by Test Type, 2018 - 2030 (USD Million)
Tables 34 U.K Veterinary Oncology Diagnostics Market, by animal type, 2018 - 2030 (USD Million)
Tables 35 UK Veterinary Oncology Diagnostics Market, by cancer type, 2018 - 2030 (USD Million)
Tables 36 UK Veterinary Oncology Diagnostics Market, by End-Use, 2018 - 2030 (USD Million)
Tables 37 France Veterinary Oncology Diagnostics Market, by Test Type, 2018 - 2030 (USD Million)
Tables 38 France Veterinary Oncology Diagnostics Market, by animal type, 2018 - 2030 (USD Million)
Tables 39 France Veterinary Oncology Diagnostics Market, by cancer type, 2018 - 2030 (USD Million)
Tables 40 France Veterinary Oncology Diagnostics Market, by End-Use, 2018 - 2030 (USD Million)
Tables 41 Italy Veterinary Oncology Diagnostics Market, by Test Type, 2018 - 2030 (USD Million)
Tables 42 Italy Veterinary Oncology Diagnostics Market, by animal type, 2018 - 2030 (USD Million)
Tables 43 Italy Veterinary Oncology Diagnostics Market, by cancer type, 2018 - 2030 (USD Million)
Tables 44 Italy Veterinary Oncology Diagnostics Market, by End-Use, 2018 - 2030 (USD Million)
Tables 45 Spain Veterinary Oncology Diagnostics Market, by Test Type, 2018 - 2030 (USD Million)
Tables 46 Spain Veterinary Oncology Diagnostics Market, by animal type, 2018 - 2030 (USD Million)
Tables 47 Spain Veterinary Oncology Diagnostics Market, by cancer type, 2018 - 2030 (USD Million)
Tables 48 Spain Veterinary Oncology Diagnostics Market, by End-Use, 2018 - 2030 (USD Million)
Tables 49 Sweden Veterinary Oncology Diagnostics Market, by Test Type, 2018 - 2030 (USD Million)
Tables 50 Sweden Veterinary Oncology Diagnostics Market, by animal type, 2018 - 2030 (USD Million)
Tables 51 Sweden Veterinary Oncology Diagnostics Market, by cancer type, 2018 - 2030 (USD Million)
Tables 52 Sweden Veterinary Oncology Diagnostics Market, by End-Use, 2018 - 2030 (USD Million)
Tables 53 Denmark Veterinary Oncology Diagnostics Market, by Test Type, 2018 - 2030 (USD Million)
Tables 54 Denmark Veterinary Oncology Diagnostics Market, by animal type, 2018 - 2030 (USD Million)
Tables 55 Denmark Veterinary Oncology Diagnostics Market, by cancer type, 2018 - 2030 (USD Million)
Tables 56 Denmark Veterinary Oncology Diagnostics Market, by End-Use, 2018 - 2030 (USD Million)
Tables 57 Norway Veterinary Oncology Diagnostics Market, by Test Type, 2018 - 2030 (USD Million)
Tables 58 Norway Veterinary Oncology Diagnostics Market, by animal type, 2018 - 2030 (USD Million)
Tables 59 Norway Veterinary Oncology Diagnostics Market, by cancer type, 2018 - 2030 (USD Million)
Tables 60 Norway Veterinary Oncology Diagnostics Market, by End-Use, 2018 - 2030 (USD Million)
Tables 61 Asia Pacific Veterinary Oncology Diagnostics Market, by country, 2018 - 2030 (USD Million)
Tables 62 Asia Pacific Veterinary Oncology Diagnostics Market, by Test Type, 2018 - 2030 (USD Million)
Tables 63 Asia Pacific Veterinary Oncology Diagnostics Market, by animal type, 2018 - 2030 (USD Million)
Tables 64 Asia Pacific Veterinary Oncology Diagnostics Market, by cancer type, 2018 - 2030 (USD Million)
Tables 65 Asia Pacific Veterinary Oncology Diagnostics Market, by End-Use, 2018 - 2030 (USD Million)
Tables 66 Japan Veterinary Oncology Diagnostics Market, by Test Type, 2018 - 2030 (USD Million)
Tables 67 Japan Veterinary Oncology Diagnostics Market, by animal type, 2018 - 2030 (USD Million)
Tables 68 Japan Veterinary Oncology Diagnostics Market, by cancer type, 2018 - 2030 (USD Million)
Tables 69 Japan Veterinary Oncology Diagnostics Market, by End-Use, 2018 - 2030 (USD Million)
Tables 70 China Veterinary Oncology Diagnostics Market, by Test Type, 2018 - 2030 (USD Million)
Tables 71 China Veterinary Oncology Diagnostics Market, by animal type, 2018 - 2030 (USD Million)
Tables 72 China Veterinary Oncology Diagnostics Market, by cancer type, 2018 - 2030 (USD Million)
Tables 73 China Veterinary Oncology Diagnostics Market, by End-Use, 2018 - 2030 (USD Million)
Tables 74 India Veterinary Oncology Diagnostics Market, by Test Type, 2018 - 2030 (USD Million)
Tables 75 India Veterinary Oncology Diagnostics Market, by animal type, 2018 - 2030 (USD Million)
Tables 76 India Veterinary Oncology Diagnostics Market, by cancer type, 2018 - 2030 (USD Million)
Tables 77 India Veterinary Oncology Diagnostics Market, by End-Use, 2018 - 2030 (USD Million)
Tables 78 Australia Veterinary Oncology Diagnostics Market, by Test Type, 2018 - 2030 (USD Million)
Tables 79 Australia Veterinary Oncology Diagnostics Market, by animal type, 2018 - 2030 (USD Million)
Tables 80 Australia Veterinary Oncology Diagnostics Market, by cancer type, 2018 - 2030 (USD Million)
Tables 81 Australia Veterinary Oncology Diagnostics Market, by End-Use, 2018 - 2030 (USD Million)
Tables 82 South Korea Veterinary Oncology Diagnostics Market, by Test Type, 2018 - 2030 (USD Million)
Tables 83 South Korea Veterinary Oncology Diagnostics Market, by animal type, 2018 - 2030 (USD Million)
Tables 84 South Korea Veterinary Oncology Diagnostics Market, by cancer type, 2018 - 2030 (USD Million)
Tables 85 South Korea Veterinary Oncology Diagnostics Market, by End-Use, 2018 - 2030 (USD Million)
Tables 86 Thailand Veterinary Oncology Diagnostics Market, by Test Type, 2018 - 2030 (USD Million)
Tables 87 Thailand Veterinary Oncology Diagnostics Market, by animal type, 2018 - 2030 (USD Million)
Tables 88 Thailand Veterinary Oncology Diagnostics Market, by cancer type, 2018 - 2030 (USD Million)
Tables 89 Thailand Veterinary Oncology Diagnostics Market, by End-Use, 2018 - 2030 (USD Million)
Tables 90 LATAM Veterinary Oncology Diagnostics Market, by country, 2018 - 2030 (USD Million)
Tables 91 LATAM Veterinary Oncology Diagnostics Market, by Test Type, 2018 - 2030 (USD Million)
Tables 92 LATAM Veterinary Oncology Diagnostics Market, by animal type, 2018 - 2030 (USD Million)
Tables 93 LATAM Veterinary Oncology Diagnostics Market, by cancer type, 2018 - 2030 (USD Million)
Tables 94 LATAM Veterinary Oncology Diagnostics Market, by End-Use, 2018 - 2030 (USD Million)
Tables 95 Brazil Veterinary Oncology Diagnostics Market, by Test Type, 2018 - 2030 (USD Million)
Tables 96 Brazil Veterinary Oncology Diagnostics Market, by animal type, 2018 - 2030 (USD Million)
Tables 97 Brazil Veterinary Oncology Diagnostics Market, by cancer type, 2018 - 2030 (USD Million)
Tables 98 Brazil Veterinary Oncology Diagnostics Market, by End-Use, 2018 - 2030 (USD Million)
Tables 99 Argentina Veterinary Oncology Diagnostics Market, by Test Type, 2018 - 2030 (USD Million)
Tables 100 Argentina Veterinary Oncology Diagnostics Market, by animal type, 2018 - 2030 (USD Million)
Tables 101 Argentina Veterinary Oncology Diagnostics Market, by cancer type, 2018 - 2030 (USD Million)
Tables 102 Argentina Veterinary Oncology Diagnostics Market, by End-Use, 2018 - 2030 (USD Million)
Tables 103 MEA Veterinary Oncology Diagnostics Market, by country, 2018 - 2030 (USD Million)
Tables 104 MEA Veterinary Oncology Diagnostics Market, by Test Type, 2018 - 2030 (USD Million)
Tables 105 MEA Veterinary Oncology Diagnostics Market, by animal type, 2018 - 2030 (USD Million)
Tables 106 MEA Veterinary Oncology Diagnostics Market, by cancer type, 2018 - 2030 (USD Million)
Tables 107 MEA Veterinary Oncology Diagnostics Market, by End-Use, 2018 - 2030 (USD Million)
Tables 108 South Africa Veterinary Oncology Diagnostics Market, by Test Type, 2018 - 2030 (USD Million)
Tables 109 South Africa Veterinary Oncology Diagnostics Market, by animal type, 2018 - 2030 (USD Million)
Tables 110 South Africa Veterinary Oncology Diagnostics Market, by cancer type, 2018 - 2030 (USD Million)
Tables 111 South Africa Veterinary Oncology Diagnostics Market, by End-Use, 2018 - 2030 (USD Million)
Tables 112 Saudi Arabia Veterinary Oncology Diagnostics Market, by Test Type, 2018 - 2030 (USD Million)
Tables 113 Saudi Arabia Veterinary Oncology Diagnostics Market, by animal type, 2018 - 2030 (USD Million)
Tables 114 Saudi Arabia Veterinary Oncology Diagnostics Market, by cancer type, 2018 - 2030 (USD Million)
Tables 115 Saudi Arabia Veterinary Oncology Diagnostics Market, by End-Use, 2018 - 2030 (USD Million)
Tables 116 UAE Veterinary Oncology Diagnostics Market, by Test Type, 2018 - 2030 (USD Million)
Tables 117 UAE Veterinary Oncology Diagnostics Market, by animal type, 2018 - 2030 (USD Million)
Tables 118 UAE Veterinary Oncology Diagnostics Market, by cancer type, 2018 - 2030 (USD Million)
Tables 119 UAE Veterinary Oncology Diagnostics Market, by End-Use, 2018 - 2030 (USD Million)
Tables 120 Kuwait Veterinary Oncology Diagnostics Market, by Test Type, 2018 - 2030 (USD Million)
Tables 121 Kuwait Veterinary Oncology Diagnostics Market, by animal type, 2018 - 2030 (USD Million)
Tables 122 Kuwait Veterinary Oncology Diagnostics Market, by cancer type, 2018 - 2030 (USD Million)
Tables 123 Kuwait Veterinary Oncology Diagnostics Market, by End-Use, 2018 - 2030 (USD Million)
Tables 124 Company Overview
Tables 125 Service Benchmarking
Tables 126 Financial Performance
Tables 127 Strategic Initiatives
List of Figures
Fig. 1 Global Veterinary Oncology Diagnostics Market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Data Analysis Models
Fig. 6 Market Formulation And Validation
Fig. 7 Data Validating & Publishing
Fig. 8 General methodology for a commodity flow analysis of Global Veterinary Oncology Diagnostics Market
Fig. 9 Commodity flow analysis
Fig. 10 Parent market analysis
Fig. 11 Market snapshot
Fig. 12 Segment snapshot
Fig. 13 Segment snapshot
Fig. 14 Competitive landscape snapshot
Fig. 15 Parent market value, 2024 (USD Billion)
Fig. 16 Ancillary market outlook, 2024
Fig. 17 Global Veterinary Oncology Diagnostics Market Dynamics
Fig. 18 Estimated animal population, 2018-2024 by key species and key countries
Fig. 19 Global Veterinary Oncology Diagnostics Market: PORTER’s analysis
Fig. 20 Global Veterinary Oncology Diagnostics Market: PESTEL analysis
Fig. 21 Global Veterinary Oncology Diagnostics Market by Animal: Key Takeaways
Fig. 22 Global Veterinary Oncology Diagnostics Market by Animal, 2024 & 2030
Fig. 23 Canine market, 2018 - 2030 (USD Million)
Fig. 24 Feline market, 2018 - 2030 (USD Million)
Fig. 25 Others market, 2018 - 2030 (USD Million)
Fig. 26 Global Veterinary Oncology Diagnostics Market by Test Type: Key Takeaways
Fig. 27 Global Veterinary Oncology Diagnostics Market by Test Type, Market Share, 2024 & 2030
Fig. 28 Blood Tests market, 2018 - 2030 (USD Million)
Fig. 29 Biopsy market, 2018 - 2030 (USD Million)
Fig. 30 Genome testing market, 2018 - 2030 (USD Million)
Fig. 31 Endoscopy market, 2018 - 2030 (USD Million)
Fig. 32 Urinalysis market, 2018 - 2030 (USD Million)
Fig. 33 Imaging market, 2018 - 2030 (USD Million)
Fig. 34 Global Veterinary Oncology Diagnostics Market by Cancer Type: Key Takeaways
Fig. 35 Global Veterinary Oncology Diagnostics Market by Cancer Type, Market Share, 2024 & 2030
Fig. 36 Lymphoma market, 2018 - 2030 (USD Million)
Fig. 37 Sarcomas market, 2018 - 2030 (USD Million)
Fig. 38 Mammary Gland Tumors market, 2018 - 2030 (USD Million)
Fig. 39 Skin Cancers market, 2018 - 2030 (USD Million)
Fig. 40 Others market, 2018 - 2030 (USD Million)
Fig. 41 Global Veterinary Oncology Diagnostics Market by End-Use: Key Takeaways
Fig. 42 Global Veterinary Oncology Diagnostics Market by End-Use, Market Share, 2024 & 2030
Fig. 43 Reference Laboratories market, 2018 - 2030 (USD Million)
Fig. 44 Veterinary hospitals and clinics market, 2018 - 2030 (USD Million)
Fig. 45 Regional market share analysis, 2024 & 2030
Fig. 46 Regional marketplace: Key takeaways
Fig. 47 North America Veterinary Oncology Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 48 Key country dynamics
Fig. 49 U.S Veterinary Oncology Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 50 Key country dynamics
Fig. 51 Canada Veterinary Oncology Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 52 Key country dynamics
Fig. 53 Mexico Veterinary Oncology Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 54 Europe Veterinary Oncology Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 55 Key country dynamics
Fig. 56 UK Veterinary Oncology Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 57 Key country dynamics
Fig. 58 Germany Veterinary Oncology Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 59 Key country dynamics
Fig. 60 France Veterinary Oncology Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 61 Key country dynamics
Fig. 62 Italy Veterinary Oncology Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 63 Key country dynamics
Fig. 64 Spain Veterinary Oncology Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 65 Key country dynamics
Fig. 66 Sweden Veterinary Oncology Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 67 Key country dynamics
Fig. 68 Denmark Veterinary Oncology Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 69 Key country dynamics
Fig. 70 Norway Veterinary Oncology Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 71 Asia Pacific Veterinary Oncology Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 72 Key country dynamics
Fig. 73 Japan Veterinary Oncology Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 74 Key country dynamics
Fig. 75 China Veterinary Oncology Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 76 Key country dynamics
Fig. 77 India Veterinary Oncology Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 78 Key country dynamics
Fig. 79 Australia Veterinary Oncology Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 80 Key country dynamics
Fig. 81 South Korea Veterinary Oncology Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 82 Key country dynamics
Fig. 83 Thailand Veterinary Oncology Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 84 Latin America Veterinary Oncology Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 85 Key country dynamics
Fig. 86 Brazil Veterinary Oncology Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 87 Key country dynamics
Fig. 88 Argentina Veterinary Oncology Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 89 Middle East and Africa Veterinary Oncology Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 90 Key country dynamics
Fig. 91 South Africa Veterinary Oncology Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 92 Key country dynamics
Fig. 93 Saudi Arabia Veterinary Oncology Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 94 Key country dynamics
Fig. 95 UAE Veterinary Oncology Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 96 Key country dynamics
Fig. 97 Kuwait Veterinary Oncology Diagnostics Market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 98 Market Participant Categorization
Fig. 99 Heat map analysis
Fig. 100 Strategic Framework

Companies Mentioned

  • Zoetis
  • Antech Diagnostics, Inc. (Mars Inc.)
  • IDEXX Laboratories, Inc.
  • Neogen Corporation
  • Gold Standard Diagnostics (Eurofins Technologies)
  • Embark Veterinary, Inc.
  • VolitionRx Limited
  • CANCAN DIAGNOSTICS
  • Oncotect
  • PetDx

Methodology

Loading
LOADING...

Table Information